%PDF-1.3
%
19 0 obj
<>>>/BBox[0 0 612 792]/Length 55>>stream
xs
w3T04PI2P0T5T0P02S04S @$P5 )1
endstream
endobj
21 0 obj
<>>>/BBox[0 0 612 792]/Length 54>>stream
xs
w3T04PI2P0T5T R
Ɩf
!\!Y\ !p )P
endstream
endobj
20 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
10 0 obj
<>>>/BBox[0 0 612 792]/Length 55>>stream
xs
w3T04PI2P0T5T0P02S04S @$P5 )1
endstream
endobj
26 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
27 0 obj
<>>>/BBox[0 0 612 792]/Length 54>>stream
xs
w3T04PI2P0T5T R
Ɩf
!\!Y\ !p )P
endstream
endobj
5 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
11 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
15 0 obj
<>>>/BBox[0 0 612 792]/Length 54>>stream
xs
w3T04PI2P0T5T R
Ɩf
!\!Y\ !p )P
endstream
endobj
1 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
23 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
24 0 obj
<>>>/BBox[0 0 612 792]/Length 54>>stream
xs
w3T04PI2P0T5T R
Ɩf
!\!Y\ !p )P
endstream
endobj
25 0 obj
<>>>/BBox[0 0 612 792]/Length 55>>stream
xs
w3T04PI2P0T5T0P02S04S @$P5 )1
endstream
endobj
16 0 obj
<>>>/BBox[0 0 612 792]/Length 55>>stream
xs
w3T04PI2P0T5T0P02S04S @$P5 )1
endstream
endobj
7 0 obj
<>>>/BBox[0 0 612 792]/Length 55>>stream
xs
w3T04PI2P0T5T0P02S04S @$P5 )1
endstream
endobj
4 0 obj
<>>>/BBox[0 0 612 792]/Length 55>>stream
xs
w3T04PI2P0T5T0P02S04S @$P5 )1
endstream
endobj
28 0 obj
<>>>/BBox[0 0 612 792]/Length 55>>stream
xs
w3T04PI2P0T5T0P02S04S @$P5 )1
endstream
endobj
6 0 obj
<>>>/BBox[0 0 612 792]/Length 54>>stream
xs
w3T04PI2P0T5T R
Ɩf
!\!Y\ !p )P
endstream
endobj
13 0 obj
<>>>/BBox[0 0 612 792]/Length 55>>stream
xs
w3T04PI2P0T5T0P02S04S @$P5 )1
endstream
endobj
17 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
18 0 obj
<>>>/BBox[0 0 612 792]/Length 54>>stream
xs
w3T04PI2P0T5T R
Ɩf
!\!Y\ !p )P
endstream
endobj
8 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
3 0 obj
<>>>/BBox[0 0 612 792]/Length 54>>stream
xs
w3T04PI2P0T5T R
Ɩf
!\!Y\ !p )P
endstream
endobj
9 0 obj
<>>>/BBox[0 0 612 792]/Length 54>>stream
xs
w3T04PI2P0T5T R
Ɩf
!\!Y\ !p )P
endstream
endobj
22 0 obj
<>>>/BBox[0 0 612 792]/Length 55>>stream
xs
w3T04PI2P0T5T0P02S04S @$P5 )1
endstream
endobj
12 0 obj
<>>>/BBox[0 0 612 792]/Length 54>>stream
xs
w3T04PI2P0T5T R
Ɩf
!\!Y\ !p )P
endstream
endobj
14 0 obj
<>>>/BBox[0 0 612 792]/Length 53>>stream
xs
w3T04PI2P0T5T0 q-Br44C@B 9 s
(P
endstream
endobj
30 0 obj
<>stream
Acrobat Distiller 8.1.0 (Windows); modified using iText 4.2.0 by 1T3XT
Arbortext Advanced Print Publisher 9.0.114/W
2016-07-25T01:37:09-07:00
2016-04-12T12:33:15+05:30
application/pdf
JMF-2015-0075-ver9-Gouveia_2P 337..345
uuid:4005e7af-da53-43bb-b01a-a9d4f2032c78
uuid:7761e633-b20a-43ba-b66b-d3540d0f3ad3
endstream
endobj
31 0 obj
<>stream
x+ |
endstream
endobj
32 0 obj
<>stream
xS**T0T0 Bih]D. r^j
endstream
endobj
33 0 obj
<>stream
x+ |
endstream
endobj
34 0 obj
<>stream
xS**T0T0 BiU)D* 9V
endstream
endobj
35 0 obj
<>stream
x+ |
endstream
endobj
36 0 obj
<>stream
xS**T0T0 Bih]9D. qaj
endstream
endobj
37 0 obj
<>stream
x+ |
endstream
endobj
38 0 obj
<>stream
xS**T0T0 Bid]1D. pa
endstream
endobj
39 0 obj
<>stream
x+ |
endstream
endobj
40 0 obj
<>stream
xS**T0T0 BiU !D. _e1
endstream
endobj
41 0 obj
<>stream
x+ |
endstream
endobj
42 0 obj
<>stream
xS**T0T0 BiUD* 8
endstream
endobj
43 0 obj
<>stream
x+ |
endstream
endobj
44 0 obj
<>stream
xS**T0T0 Bid]D. qdj
endstream
endobj
45 0 obj
<>stream
x+ |
endstream
endobj
46 0 obj
<>stream
xS**T0T0 BiUD* :
endstream
endobj
47 0 obj
<>stream
x+ |
endstream
endobj
48 0 obj
<>stream
xS**T0T0 Bih] D. pa
endstream
endobj
50 0 obj
<>stream
/GS1 gs
BT
/F3 1 Tf
10.4607 0 0 10.4607 54.5952 724.8187 Tm
0 0 0 rg
0 Tc
0 Tw
[(The)-303.3(research)-297.5(question)-302.1(asked)-300.7(in)-297.5(this)-303.5(systematic)-301.2(review)-298.1(of)]TJ
-1.0026 -1.0948 TD
[(clinical)-303(trials)-306.2(was:)-298.9()45.8(What)-299.3(is)-304.1(the)-300.3(effect)-302.6(of)-299.7(the)-305.7(intake)-302.6(of)-299.7(ses-)]TJ
T*
[(ame)-303.1(seeds)-301.9(and)-298.1(derivatives)-296.8(on)-300.7(oxidative)-300.6(stress?)47.8()]TJ
1.0026 -1.0948 TD
[(Two)-287.1(researchers)-286.9(were)-287.9(in)-281.2(charge)-290.5(of)-283.4(the)-284.1(search)-286.3(for)-286.4(articles)]TJ
-1.0026 -1.0948 TD
[(and)-314.4(their)-315(selection,)-310.7(as)-311.5(well)-316.2(as)-311.5(the)-311.2(assessment)-315.4(of)-310.5(the)-311.2(risk)-311.1(of)]TJ
0 -1.1002 TD
[(bias)-300.1(in)-302.9(the)-300.3(results)-298.3(of)-299.7(the)-300.3(articles)-301(selected)-298.6(in)-302.9(duplicate.)]TJ
/F4 1 Tf
0 -2.054 TD
[(Search)-337.2(strategy)]TJ
/F3 1 Tf
1.0026 -1.6421 TD
[(The)-222(following)-214(seven)-219.4(sources)-222.2(of)-218.4(information)-221.9(were)-217.4(used)-222(for)]TJ
-1.0026 -1.0948 TD
[(the)-267.8(bibliographic)-263.7(research)-265(of)-267.2(this)-260.2(systematic)-268.7(review:)-266.4(Lilacs,)]TJ
T*
[(PubMed,)-376.5(ISI)-375.4(Web)-376.8(of)-375.6(Knowledge,)-374.3(Cochrane)-376.4(Library,)-378.5(Sco-)]TJ
T*
[(pus,)-435.3(Trip)-434.4(Database,)-435.3(and)-433.6(Scielo.)-434.1(The)-433.4(bibliographic)-437.1(search)]TJ
T*
[(began)-310.4(in)-302.9(September)-302.4(2013,)-308(and)-303.5(ended)-304.9(in)-302.9(January)-307.7(2014.)-302.6(The)]TJ
T*
[(languages)-344.9(of)-348.5(the)-343.7(articles)-349.7(sought)-341.9(were)-347.5(English,)-341.8(Portuguese,)]TJ
0 -1.1002 TD
[(and)-303.5(Spanish.)]TJ
1.0026 -1.0948 TD
[(In)-343.1(the)-343.7(site)-345.7(of)-343.1(the)-343.7(Virtual)-340.3(Health)-344.7(Library)-341.3(\(BVS\),)-345.5(the)-343.7(fol-)]TJ
-1.0026 -1.0948 TD
[(lowing)-217(keyword)-209(descriptors)-214.6(were)-217.4(initially)-216.3(sought)-211.8(in)-210.8(English,)]TJ
T*
[(Portuguese,)-383.1(and)-384.8(Spanish:)-380.2(sesame,)-386.1(our,)-385.1(risk,)-380.9(lipid)-384.4(prole,)]TJ
T*
[(cardiovascular,)-335(seed,)-328.5(oil,)-330.1(sesame)-332.6(oil,)-330.1(and)-330.6(capsule.)-330.7(The)-330.4(fol-)]TJ
T*
[(lowing)-330.8(were)-331.2(identied:)]TJ
/F4 1 Tf
9.7824 0 TD
(Sesamum)Tj
/F3 1 Tf
3.7666 0 TD
[(,)-329.9(our,)-325.5(risk)-332.8(factors,)-324.5(dysli-)]TJ
-13.549 -1.0948 TD
[(pidemias,)-409.4(cardiovascular)-406.2(diseases,)-407.6(seeds,)-404.2(oils,)-405.8(sesame)-408.5(oil,)]TJ
T*
[(and)-303.5(capsule.)]TJ
1.0026 -1.0948 TD
[(In)-440.6(the)-446.7(next)-439.8(stage)-443.8(of)-446(the)-441.2(search)-443.4(strategy,)-440.1(the)-446.6(following)]TJ
-1.0026 -1.0948 TD
[(keywords)-203.3(and)-200.6(their)-206.6(synonyms)-197.9(were)-201.1(sought)-200.9(in)-205.4(study)-202.4(titles)-201(and)]TJ
T*
(abstracts:)Tj
/F4 1 Tf
4.3194 0 TD
[(Sesamum)-529.7(brasiliensis)]TJ
/F3 1 Tf
8.9044 0 TD
(,)Tj
/F4 1 Tf
.7804 0 TD
(gergelim-do-Brasil)Tj
/F3 1 Tf
7.6688 0 TD
[(,)-530.4(ses-)]TJ
-21.673 -1.1002 TD
[(ame,)-389.2(our,)-379.7(risk)-381.6(factors,)-384.1(dyslipidemias,)-381(cardiovascular)-384.5(dis-)]TJ
0 -1.0948 TD
[(eases,)-305.4(and)-298.1(lipids.)]TJ
1.0026 -1.0948 TD
[(The)-357.5(research)-357.1(was)-352.3(conducted)-354.6(in)-357.1(articles)-355.2(published)-354.9(in)-351.7(the)]TJ
-1.0026 -1.0948 TD
-.018 Tc
[(last)-316.9(15)-314.7(years)-315.9(a).9(nd)-314.7(the)-313.5(t)-2.6(erms)-315.9(were)-318.9(u)-.3(sed)-314.7(a).8(lone)-318.9(and)5.1(/)-2.6(or)-313.7(combina-)]TJ
T*
-.0171 Tc
[(tio)6(ns)-201.2(of)-204.4(t)3.8(h).6(em.)-200.7(T).7(here)-204.2(are)-204.2(n).6(o)-200(l)3.8(imi)3.8(t)-1.7(s)-201.2(t)3.8(o)-205.4(t)3.8(he)-204.2(s)4.8(e)1.8(arch)-200(in)-200(relati)3.8(on)-200(to)-200(th)6(e)]TJ
T*
-.0175 Tc
[(intervention)-308.8(time,)-314.9(c)1.3(oun)5.6(try,)-309.5(an)5.6(d)-314.2(u).2(se)-313(o)5.6(f)-313.2(medicines.)-314.9(Th)5.6(ere)-313(were)]TJ
T*
-.0177 Tc
[(limits)-299.3(t)-2.3(o)-298.1(t)-2.3(h)5.4(e)-302.3(pop)5.4(ulation)-298.1(w)1.2(ith)-303.5(s)4.2(ome)-296.9(k)0(ind)-298.1(o)0(f)-297.1(c)1.2(hronic)-302.3(d)0(isease.)]TJ
/F4 1 Tf
0 -2.531 TD
0 Tc
[(Eligibility)-334.7(criteria)]TJ
/F3 1 Tf
1.0026 -1.6421 TD
[(This)-333.6(review)-330.6(included)-332.3(clinical)-335.5(trials)-333.3(on)-333.2(the)-332.8(intake)-335.1(of)-332.2(ses-)]TJ
-1.0026 -1.1002 TD
[(ame)-449.5(seeds)-442.8(and)-444.4(derivatives,)-447.8(which)-442.6(assessed)-445.2(the)-446.6(following)]TJ
0 -1.0948 TD
[(outcomes)-229.1(related)-233.9(to)-227(oxidative)-230.1(stress:)-229(the)-229.9(antioxidant)-224.1(defense)]TJ
T*
[(system,)-352.8(such)-346.7(as)-354.9(vitamin)-348.7(C,)-346.8(vitamin)-348.7(E,)-355.4(beta-carotene)-351(\(vita-)]TJ
T*
[(min)-248.1(A)-246.7(precursor\),)-240.2(SOD,)-249.6(GSH,)-244.2(GPx)-240.7(and)-249.3(CAT;)-241.1(and)-249.3(oxidative)]TJ
T*
[(stress)-304.1(markers,)-296(such)-303.3(as)-300.7(TBARS)-295.9(and)-303.5(MDA.)]TJ
1.0026 -1.0948 TD
[(The)-493(inclusion)-492.6(criteria)-488.5(of)-494.8(this)-493.2(systematic)-490.9(review)-493.2(were:)]TJ
-1.0026 -1.0948 TD
[(clinical)-400.5(trials)-403.7(written)-394.5(in)-400.5(English,)-396(Portuguese,)-399.4(and)-395.7(Spanish)]TJ
T*
[(assessing)-322.6(the)-316.6(outcomes)-315.8(of)-316(interest,)-317.7(that)-317.4(is,)-319.7(the)-316.6(effect)-318.8(of)-316(the)]TJ
T*
[(intake)-356.8(of)-359.3(sesame)-359.7(seeds)-356.1(and)-357.7(derivatives)-356.4(on)-354.9(oxidative)-354.8(stress)]TJ
T*
[(and)-422.8(the)-419.6(participants)-422.2(must)-421.4(have)-420.2(a)-420.1(chronic)-422.6(disease)-424.8(such)-417.1(as)]TJ
T*
[(hypertension,)-299(type)-298.9(2)-302.1(diabetes)-299.8(for)-297.3(example.)]TJ
1.0026 -1.1002 TD
[(The)-465.9(exclusion)-467.6(criteria)-472.2(of)-467.7(this)-471.5(systematic)-463.8(review)-471.6(were:)]TJ
-1.0026 -1.0948 TD
[(letter-type)-340.1(reports;)-332.6(interventions)-329.9(using)-337.8(sesame)-332.6(as)-338.6(an)-332(ingre-)]TJ
T*
[(dient)-386.4(for)-384(cakes)-380.8(or)-381(cereal)-389.1(bars;)-379(articles)-387.7(with)-382.4(outcomes)-380.8(dif-)]TJ
T*
[(ferent)-406.7(from)-399.7(those)-401.7(of)-397.2(interest;)-405.9(and)-401.1(articles)-398.5(in)-405.9(idioms)-399.1(other)]TJ
T*
[(than)-304.3(those)-298.7(of)-299.7(the)-300.3(inclusion)-297.5(criteria.)]TJ
/F4 1 Tf
0 -2.531 TD
[(Assessment)-336(of)-335.4(the)-332.8(risk)-333.8(of)-330(bias)]TJ
/F3 1 Tf
1.0026 -1.6421 TD
[(A)-246.7(bias)-245.9(is)-244.5(a)-246.7(systematic)-247(error)-248.9(or)-245.5(deviation)-241(from)-247.9(the)-246.1(truth,)-245(in)]TJ
-1.0026 -1.0948 TD
[(results)-450.1(or)-451.4(inferences,)-448(and)-449.9(can)-448.7(lead)-449.5(to)-449.2(underestimation)-445.9(or)]TJ
T*
[(overestimation)-301(of)-299.7(the)-300.3(true)-297.9(intervention)-297.6(effect.)]TJ
7.4718 0 0 6.641 237.3732 75.685 Tm
(22)Tj
10.4607 0 0 10.4607 329.5558 724.8187 Tm
[(The)-216.6(risk)-213.6(of)-213(bias)-213.4(in)-216.2(the)-213.6(results)-211.6(of)-218.4(the)-213.6(studies)-212.6(selected)-217.3(in)-210.8(this)]TJ
-.9972 -1.0948 TD
[(review)-422.8(was)-417.3(assessed)-423.5(by)-425.4(two)-419.5(researchers)-422.4(according)-424(to)-416.7(the)]TJ
T*
[(criteria)-320.4(of)-321.4(the)]TJ
/F4 1 Tf
5.8694 0 TD
[(Cochrane)-320.2(Handbook)-317(for)-319(Systematic)-319.6(Reviews)]TJ
-5.8694 -1.0948 TD
[(of)-557.6(Interventions)]TJ
/F3 1 Tf
6.6282 0 TD
[(,)-557.5(version)-560.5(5.1,)]TJ
7.4718 0 0 6.641 449.2912 694.3746 Tm
(22)Tj
10.4607 0 0 10.4607 462.614 690.4628 Tm
[(as)-566.3(follows:)-558.1()45.8(low)-558(risk,)44.2()]TJ
-13.717 -1.0948 TD
[()51.2(high)-444(risk,)49.7()-447.4(and)-439()45.8(unclear)-446.1(risk.)49.7()-442(This)-447.4(systematic)-442.1(review)]TJ
0 -1.1002 TD
[(used)-438.8(a)-436.4(standard)-438.6(Cochrane)-441.5(Collaborations)-436.5()45.8(risk)-438.8(of)-435.2(bias)43.7()]TJ
0 -1.0948 TD
[(table)-455.7(with)-463.7(the)-457.5(following)-457.9(features)-458.1(of)-462.3(interest:)-460.1(random)-456.3(se-)]TJ
T*
[(quence)-627.5(generation)-630.8(\(selection)-634.2(bias\);)-629.1(allocation)-630.8(sequence)]TJ
T*
[(concealment)-412(\(selection)-417.4(bias\);)-412.3(blinding)-412.8(of)-418.9(participants)-411.4(and)]TJ
T*
[(personnel)-345.1(\(performance)-343.7(bias\);)-352.7(blinding)-342.3(of)-348.5(outcome)-343.1(assess-)]TJ
T*
[(ment)-435.2(\(detection)-443.3(bias\);)-439.4(incomplete)-434.3(outcome)-440.7(data)-438.6(\(attrition)]TJ
T*
[(bias\);)-298.5(and)-298.1(selective)-299.4(outcome)-299.8(reporting)-297.5(\(reporting)-300.6(bias\).)]TJ
.9972 -1.0948 TD
[(The)-287.1(inclusion)-281.3(and)-281.8(exclusion)-288.7(of)-283.4(the)-284.1(articles)-284.7(in)-286.7(this)-281.9(review)]TJ
-.9972 -1.0948 TD
[(were)-244.5(based)-251.9(on)-246.5(a)-246.7(consensus)-248.7(achieved)-246.4(by)-246.5(the)-246.1(two)-251.5(researchers.)]TJ
T*
[(If)-363.7(in)-362.5(doubt,)-363(there)-365.8(is)-363.7(a)-365.9(third)-365(researcher)-363(who)-363.1(participated)-365.7(in)]TJ
T*
[(the)-300.3(selection.)]TJ
/F4 1 Tf
0 -2.5364 TD
[(Data)-331.4(collection)]TJ
/F3 1 Tf
.9972 -1.6421 TD
[(The)-352.1(articles)-349.7(were)-352.9(systematically)-353(reviewed)-348.3(regarding)-348.3(the)]TJ
-.9972 -1.0948 TD
[(effect)-443.5(of)-446(the)-441.2(intake)-448.9(of)-440.6(sesame)-446.5(and)-444.4(its)-445.8(derivatives)-443.1(on)-441.6(the)]TJ
T*
[(antioxidant)-316.2(defense)-322.8(system)-315.6(and)-319.8(oxidative)-322.3(stress)-320.4(markers)-318.4(in)]TJ
T*
[(patients)-259.8(with)-257.8(systemic)-259.6(hypertension,)-261.1(dyslipidemia,)-256.5(and)-260.2(type)]TJ
T*
[(2)-291.3(diabetes)-294.3(mellitus.)-290.4(The)-292.5(articles)-295.5(selected)-293.1(were)-293.3(organized)-293.9(in)]TJ
T*
[(tables,)-384.3(and)-384.8(classied)-388.5(according)-386.1(to)-389.6(the)-387(populations)-381.5(studied)]TJ
T*
[(and)-314.4(the)-316.6(outcomes)-315.8()45.8(antioxidant)-313.8(defense)-317.4(system)49.9()-317.3(and)-314.4()45.8(oxi-)]TJ
T*
[(dative)-221.3(stress)-228.2(markers)47.1(.)-224.5(In)-229.2(the)-224.4()45.8(antioxidant)-221.7(defense)-225.3(system)44.5()]TJ
0 -1.1002 TD
[(outcome,)-315.3(antioxidants,)-315.3(such)-319.6(as)-322.4(vitamin)-316.2(C,)-319.7(vitamin)-316.2(E,)-317.5(beta-)]TJ
0 -1.0948 TD
[(carotene,)-277.2(SOD,)-282.1(GSH,)-276.7(GPx,)-283.3(and)-276.4(CAT,)-282.9(were)-277(assessed.)-281.9(In)-278(the)]TJ
T*
[()51.2(oxidative)-482.4(stress)-482.9(markers)47.1()-485.4(outcome,)-477.9(TBARS)-485.6(and)-482.4(MDA)]TJ
T*
[(were)-472.1(assessed.)-471.6(A)-474.3(meta-analysis)-473.6(could)-470.9(not)-474.9(be)-472.9(performed,)]TJ
T*
[(because)-360.6(of)-359.3(the)-354.5(great)-360.3(heterogeneity)-362(of)-359.3(study)-354.1(designs,)-361.4(inter-)]TJ
T*
[(ventions,)-296(and)-298.1(populations.)]TJ
/F1 1 Tf
9.7282 -2.531 TD
(RESULTS)Tj
/F4 1 Tf
-9.7282 -1.7126 TD
[(Search)-331.8(for)-329.8(articles)-336.9(and)-331.8(data)-327.2(collection)]TJ
/F3 1 Tf
.9972 -1.6476 TD
[(Our)-291.7(search)-297.1(retrieved)-289.7(3417)-292.5(abstracts,)-292.4(of)-294.3(which)-290.9(1432)-292.5(were)]TJ
-.9972 -1.0948 TD
[(nonduplicate)-316.9(abstracts.)-319.5(At)-323.4(the)-316.6(end,)-319.1(seven)-322.4(articles)-322.7(with)-317.4(out-)]TJ
T*
[(comes)-350.3(related)-353.1(to)-346.3(oxidative)-354.8(stress)-347.5(\(antioxidant)-351.8(defense)-349.9(sys-)]TJ
T*
[(tem)-463.7(and)-466.1(oxidative)-468.6(stress)-466.7(markers\))-467.7(were)-466.7(selected)-472(for)-465.3(this)]TJ
T*
(review.)Tj
.9972 -1.0948 TD
[(Figure)-264.8(1)-269.6(depicts)-264.4(the)-267.8(owchart)-270.4(of)-267.2(the)-267.8(search)-264.6(and)-271(selection)]TJ
-.9972 -1.0948 TD
[(of)-299.7(the)-294.9(articles)-306.4(for)-297.3(this)-298.1(review.)]TJ
/F4 1 Tf
0 -2.531 TD
[(Characteristics)-332.5(of)-330(the)-332.8(studies)]TJ
/F3 1 Tf
.9972 -1.6421 TD
[(Of)-396(the)-397.9(12)-398.3(full)-393.5(articles)-398.5(assessed)-396.4(for)-400.3(eligibility)-394.5(with)-393.2(oxi-)]TJ
-.9972 -1.1002 TD
[(dative)-400.1(stress)-401.6(as)-398.2(an)-402.5(outcome,)-396.6(ve)-397.9(were)-401.7(excluded)-404.7(from)-394.3(the)]TJ
0 -1.0948 TD
[(systematic)-312(review)-314.4(due)-308.9(to)-313.8(heterogeneity,)-312.5(because)-311.8(they)-309.8(eval-)]TJ
T*
[(uated)-442.7(either)-447.9(healthy)-442.1(populations)-441.1(or)-446(different)-447.1(sesame)-441(pre-)]TJ
T*
[(sentations,)-430.9(which)-431.8(made)-431.8(data)-433.2(analysis)-432.2(difcult.)-428.3(Therefore,)]TJ
T*
[(seven)-295.3(studies)-299.3(were)-304.1(selected)-298.6(for)-302.7(qualitative)-295.6(analysis.)]TJ
.9972 -1.0948 TD
[(Table)-507.5(1)-513.5(shows)-503.6(the)-511.7(major)-508.7(characteristics)-512.2(of)-505.6(the)-511.7(seven)]TJ
-.9972 -1.0948 TD
-.0299 Tc
[(clinical)-242.1(trials)-241.1(r)5(e)-.2(trieved,)-240.6(ve)-238.7(o)-1.4(f)-238.9(w)-.2(hich)-239.9(were)-238.7(r)-.4(andomized,)]TJ
7.4718 0 0 6.641 535.7479 110.0409 Tm
-.0372 Tc
[(10)7.5(,11,)7.9(14)7.5(16)]TJ
10.4607 0 0 10.4607 319.1243 94.6771 Tm
0 Tc
[(two)-224.4(were)-228.2(placebo)-227.3(contro)-7.9(lled,)]TJ
7.4718 0 0 6.641 440.2203 98.589 Tm
(13)Tj
10.4607 0 0 10.4607 450.0849 94.6771 Tm
[(and)-222.2(one,)-226.9(doubl)-6.1(e-blind.)]TJ
7.4718 0 0 6.641 543.9683 98.589 Tm
(13)Tj
10.4607 0 0 10.4607 553.8329 94.6771 Tm
(The)Tj
-22.4372 -1.0948 TD
[(sesame)-473.6(presentations)-474(in)-470.9(the)-468.3(seven)-474.1(clinical)-476.4(trials)-468.7(were)-472.1(as)]TJ
T*
[(follows:)-232.9(sesame)-235.1(oil,)-227.2(four)-230.9(studies)]TJ
7.4718 0 0 6.641 453.6566 75.685 Tm
[(101)-10.7(2,14)]TJ
10.4607 0 0 10.4607 481.7762 71.7732 Tm
[(;)-228.4(sesame)-235.1(our,)-227.9(one)]TJ
7.4718 0 0 6.641 559.729 75.685 Tm
(16)Tj
10.4607 0 0 10.4607 567.2125 71.7732 Tm
(;)Tj
/F9 1 Tf
9.9626 0 0 9.9626 44.1071 748.6864 Tm
.0071 Tc
[(33)7.1(8)]TJ
/F10 1 Tf
22.7053 0 TD
0 Tc
[(GOUV)-7(EIA)-335.5(ET)-338.5(AL.)]TJ
ET
endstream
endobj
61 0 obj
<>stream
/GS1 gs
BT
/F3 1 Tf
10.4607 0 0 10.4607 41.8394 360.8503 Tm
0 0 0 rg
0 Tc
0 Tw
[(black)-236.7(sesame)-240.5(meal)-238.9(capsules,)-238.4(one)]TJ
7.4718 0 0 6.641 178.5826 364.7621 Tm
(13)Tj
10.4607 0 0 10.4607 186.0661 360.8503 Tm
[(;)-233.9(and)-238.5(white)-233.5(sesame)-240.5(seeds,)]TJ
-13.7875 -1.0948 TD
(one.)Tj
7.4718 0 0 6.641 59.6409 353.3101 Tm
(15)Tj
10.4607 0 0 10.4607 70.1291 349.3983 Tm
[(Most)-290.3(studies)-293.9(used)-287.1(only)-289.3(sesame)-294.7(and)-287.3(its)-294.1(derivative)-9.7(s)-287(a)0(s)]TJ
-2.7044 -1.0948 TD
[(dietar)-8.9(y)-405.1(supplementat)-9.9(ion)-409.9(and)-406.5(instr)-8.5(ucted)-410.1(the)-408.7(partic)-8.9(ipants)-407.9(to)]TJ
T*
[(maintain)-378.7(their)-369.2(usual)-374.6(diets)-8.3(.)]TJ
7.4718 0 0 6.641 154.2614 330.4062 Tm
(1015)Tj
10.4607 0 0 10.4607 176.8818 326.4944 Tm
[(Only)-369.4(the)-370.8(clinica)-9.5(l)-369.4(trial)-376.8(with)]TJ
-12.9095 -1.0948 TD
[(hyperlip)-7.3(idemia)-211.2(individuals)-210.2(recommended)-213.5(a)-203.4(stan)-7.5(dard)-203.6(diet)-209(for)]TJ
0 -1.1002 TD
[(two)-240.7(weeks)-245.3(\(run-in\).)]TJ
7.4718 0 0 6.641 123.9874 307.5023 Tm
(16)Tj
10.4607 0 0 10.4607 133.9653 303.5338 Tm
[(Except)-240.5(for)-243.1(one)-238.5(study)-245.7(reporting)-243.3(on)-241.1(530)]TJ
-8.8069 -1.0948 TD
[(partic)-8.9(ipants,)]TJ
7.4718 0 0 6.641 93.5433 296.0503 Tm
.0084 Tc
(10)Tj
10.4607 0 0 10.4607 105.0519 292.0818 Tm
0 Tc
[(the)-387(others)-383(inclu)-7.1(ded)-379.4(a)-387.6(small)-383(number)-385.8(of)-381(par-)]TJ
-6.0429 -1.0948 TD
[(ticipants)-11.3(.)]TJ
7.4718 0 0 6.641 80.1637 284.5984 Tm
(1116)Tj
/F4 1 Tf
10.4607 0 0 10.4607 41.8394 249.3353 Tm
[(Assessment)-336(of)-330(the)-332.8(risk)-333.8(of)-335.4(bias)]TJ
/F3 1 Tf
1.0026 -1.6421 TD
[(Seven)-480.6(clinical)-487.3(trials)-485(assessing)-485.2(the)-484.6(outcome)-484(of)-484(interest)]TJ
-1.0026 -1.0948 TD
[(were)-363.7(included)-359.4(for)-362.3(analysis)-361.8(of)-359.3(the)-365.4(risk)-359.9(of)-359.3(bias,)-364.4(by)-360.3(use)-358.9(of)-364.7(a)]TJ
T*
[()45.8(risk)-297.9(of)-299.7(bias)49.2()-301.1(table)-298.5(\(Table)-299.1(2\).)]TJ
1.0026 -1.0948 TD
[(All)-297.1(studies)-299.3(had)-303.5(at)-296.3(least)-305.1(one)-298.1(item)-302(at)-296.3(high)-300.1(risk)-300.3(for)-297.3(bias.)-304.8(Of)]TJ
-1.0026 -1.0948 TD
[(the)-419.6(seven)-414.5(studies,)-417.8(four)-415.1(were)-417.9(randomized,)-411.9(and)-417.3(three,)-419.3(non-)]TJ
0 -1.1002 TD
[(randomized,)-249.3(generating)-251.4(high)-251.3(risk)-251.5(of)-250.9(selection)-251.8(bias.)-250.6(The)-249.1(four)]TJ
0 -1.0948 TD
[(randomized)-434.3(clinical)-433.1(trials)-436.2(have)-436.4(not)-431.6(described)-436(the)-435.8(method)]TJ
T*
[(used)-249.1(to)-248.7(generate)-250.8(the)-246.1(randomization)-250.2(sequence)-245.3(and)-249.3(to)-248.7(conceal)]TJ
T*
[(the)-300.3(allocation)-300.2(sequence.)]TJ
1.0026 -1.0948 TD
[(The)-249.1(lack)-254.4(of)-250.9(blinding)-250.2(was)-249.3(the)-251.5(most)-253.3(common)-252.2(cause)-250.7(of)-250.9(high)]TJ
-1.0026 -1.0948 TD
[(risk)-213.6(of)-213(bias.)-212.7(Only)-212.2(one)-211.4(clinical)-210.9(trial)-214.2(was)-211.4(double-blind,)-209.1(but)-214.8(had)]TJ
T*
[(no)-327.8(accurate)-325.5(information)-324.9(on)-327.8(the)-327.4(blinding)-320.6(process)-330.6(of)-326.8(partici-)]TJ
T*
[(pants)-206.6(and)-200.6(personnel,)-203.5(potentially)-204.7(producing)-198.8(biases)-205.2(against)-204.8(the)]TJ
T*
[(effects)-383.6(of)-381(the)-381.6(intervention,)-378.2(generating)-376(a)-382.2(high)-381.4(risk)-381.6(for)-378.6(per-)]TJ
T*
[(formance)-298.3(and)-303.5(detection)-299.4(biases.)]TJ
27.2878 27.6346 TD
[(All)-438(studies)-440.2(reported)-436.4(the)-435.8(results)-439.2(regarding)-440.5(all)-438(outcomes)]TJ
-1.0026 -1.0948 TD
[(proposed,)-296(characterizing)-303(low)-300.3(risk)-300.3(for)-297.3(reporting)-297.5(bias.)]TJ
1.0026 -1.0948 TD
[(The)-476.8(feature)-485.4()51.2(incomplete)-480.7(outcome)-478.6(data)46.1()-479.9(could)-481.8(not)-480.4(be)]TJ
-1.0026 -1.0948 TD
[(observed)-317.2(in)-313.8(the)-311.2(articles)-317.2(selected.)-314.1(Therefore,)-315.9(the)-316.6(risk)-316.6(for)-313.5(at-)]TJ
T*
[(trition)-301.6(bias)-300.1(was)-298.1(unclear.)]TJ
/F4 1 Tf
0 -1.9023 TD
[(Effects)-336.9(of)-330(sesame)-331.8(on)-333.2(oxidative)-331.9(stress)]TJ
/F3 1 Tf
1.0026 -1.6421 TD
[(The)-205.8(large)-214(majority)-205.4(of)-207.6(the)-213.6(articles)-208.8(selected)-211.8(has)-207.2(assessed)-212.2(the)]TJ
-1.0026 -1.0948 TD
[(effects)-318.6(of)-316(sesame)-316.4(and)-314.4(its)-315.8(derivatives)-318.4(on)-311.5(the)-316.6(following)-317(anti-)]TJ
T*
[(oxidant)-340.3(parameters:)-336.5(vitamin)-337.9(C)]TJ
7.4718 0 0 6.641 446.9668 258.9731 Tm
(1012)Tj
10.4607 0 0 10.4607 465.6755 255.0614 Tm
[(;)-336.8(vitamin)-337.9(E)]TJ
7.4718 0 0 6.641 514.2046 258.9731 Tm
(11,12,14)Tj
10.4607 0 0 10.4607 540.3967 255.0614 Tm
[(;)-336.8(beta-)]TJ
-21.375 -1.0948 TD
[(ca)16(r)13.2(o)0(t)16.8(e)13.4(ne)]TJ
7.4718 0 0 6.641 351.5527 247.5212 Tm
[(10)21.2(1)28.8(2)]TJ
10.4607 0 0 10.4607 369.7511 243.6094 Tm
.2772 Tc
[(;S)277.2(O)295.3(D)]TJ
7.4718 0 0 6.641 396.1133 247.5212 Tm
0 Tc
[(10)28.8(1)28.8(4)]TJ
10.4607 0 0 10.4607 414.3117 243.6094 Tm
.2772 Tc
[(;G)290.7(S)277.2(H)]TJ
7.4718 0 0 6.641 440.6172 247.5212 Tm
0 Tc
[(9)28.8(11)]TJ
10.4607 0 0 10.4607 455.1873 243.6094 Tm
.2772 Tc
[(;G)290.6(P)277.2(x)]TJ
7.4718 0 0 6.641 479.2251 247.5212 Tm
0 Tc
[(9)28.8(11)28.8(,1)21.6(3)]TJ
10.4607 0 0 10.4607 502.8093 243.6094 Tm
[(;)-277.2(a)0(n)20.3(d)-275(CA)18.3(T.)]TJ
7.4718 0 0 6.641 549.5809 247.5212 Tm
[(10)28.8(1)21.2(2)]TJ
10.4607 0 0 10.4607 316.7999 232.1574 Tm
[(The)-335.9(oxidative)-338.5(stress)-336.6(markers)-340.1(assessed)-342.2(were)-331.2(TBARS)]TJ
7.4718 0 0 6.641 539.7731 236.0692 Tm
[(1013,)-11.9(15)]TJ
10.4607 0 0 10.4607 316.7999 220.7054 Tm
[(and)-303.5(MDA.)]TJ
7.4718 0 0 6.641 362.0409 224.6173 Tm
(13)Tj
10.4607 0 0 10.4607 327.2881 209.2535 Tm
[(Of)-336.4(the)-338.3(seven)-338.6(articles,)-338.2(three)-338.7(have)-338.9(been)-333.4(performed)-340.5(on)-333.2(pa-)]TJ
-1.0026 -1.0948 TD
[(tients)-372.2(with)-366.1(systemic)-368(hypertension.)]TJ
7.4718 0 0 6.641 463.1243 201.7133 Tm
(1012)Tj
10.4607 0 0 10.4607 485.688 197.8015 Tm
[(Those)-366.8(studies)-369.8(have)]TJ
-16.145 -1.0948 TD
[(used)-395.4(sesame)-397.7(oil)-390.4(\(35)-168.2(g\),)-391.1(and)-395.7(reported)-393.1(an)-397.1(increase)-392.9(in)-395.1(seven)]TJ
0 -1.1002 TD
[(antioxidants)-234.7(assessed,)-233.1(as)-230.2(well)-234.9(as)-230.2(a)-235.9(reduction)-232.3(in)-232.5(the)-229.9(oxidative)]TJ
0 -1.0948 TD
[(stress)-412.5(marker,)-404.6(TBARS)-409.7(\(Table)-407.5(2\).)-412.8(In)-408.1(addition,)-405.4(the)-408.7(articles)]TJ
T*
[(with)-301.1(a)-300.9(60-day)-303.7(intervention)]TJ
7.4718 0 0 6.641 429.3353 155.9055 Tm
(10)Tj
10.4607 0 0 10.4607 439.9936 151.9369 Tm
[(have)-300.9(shown)-301.9(a)-300.9(greater)-301.1(increase)]TJ
-11.7768 -1.0948 TD
[(in)-405.9(antioxidants,)-402(such)-406.3(as)-403.7(vitamin)-402.9(E)-404.9(\(90.12%)-404.8(increase\))-406.7(and)]TJ
T*
[(beta-carotene)-356.4(\(112.99%)-349.2(increase\),)-357.3(as)-354.9(compared)-353.5(with)-355.3(those)]TJ
T*
[(with)-301.1(a)-300.9(45-day)-298.3(intervention.)]TJ
7.4718 0 0 6.641 431.9432 121.4929 Tm
(11,12)Tj
10.4607 0 0 10.4607 327.2881 106.1291 Tm
[(One)-486.6(study)-484.2(with)-490.8(prehypertensive)-487.3(individuals)-481.2(and)-487.8(using)]TJ
-1.0026 -1.0948 TD
[(black)-215(sesame)-218.8(meal)-217.2(capsules)-212(\(18)-217(capsules)-212(adding)-214.8(up)-214(to)-216.2(7.56)-163.1(g)]TJ
T*
[(of)-310.5(sesame)-311(per)-313.4(day\))-306.5(has)-310.1(reported)-311.8(a)-311.7(29.93%)-304.2(increase)-311.6(in)-313.8(vita-)]TJ
T*
[(min)-302.3(E)-296.5(and)-298.1(a)-300.9(33.33%)-298.8(reduction)-297.3(in)-302.9(MDA)]TJ
7.4718 0 0 6.641 485.6313 75.685 Tm
(13)Tj
10.4607 0 0 10.4607 496.2329 71.7732 Tm
[(\(Table)-299.1(2\).)]TJ
ET
q
324.929 0 0 338.287 41.839 393.959 cm
/Im1 Do
Q
BT
/F1 1 Tf
8.9663 0 0 8.9663 390.2739 563.7542 Tm
[(FIG.)-385.4(1.)]TJ
/F3 1 Tf
4.1668 0 TD
[(Flowchart)-392.3(of)-381(the)-390.7(search)-387.5(and)-393(selection)]TJ
-4.1668 -1.1128 TD
[(of)-330.4(the)-333.8(articles.)]TJ
/F10 1 Tf
9.9626 0 0 9.9626 231.7606 748.6864 Tm
[(SESAM)-10.7(E)-334(AND)-338.6(OXIDATI)-9.5(VE)-336.3(STRES)-7.8(S)]TJ
/F9 1 Tf
32.0435 0 TD
.0071 Tc
[(33)7.1(9)]TJ
ET
endstream
endobj
63 0 obj
<>stream
Adobe d C
s !1AQa"q2B#R3b$r%C4Scs5D'6Tdt&
EFVU(eufv7GWgw8HXhx)9IYiy*:JZjz ? yCaޥM-F/2]A